Achar S et al
Cardiac and metabolic effects of anabolic-androgenicsteroid abuse on lipids, blood pressure, left ventricular dimensions, andrhythm
Am J Cardiol. 2010 Sep 15;106(6):893-901

Angell P et al
Anabolic steroids and cardiovascular risk
Sports Med.2012 Feb 1;42(2):119-34

Bagatell, C. J. et al
Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men
Journal of Clinical Endocrinology and Metabolism, 1994 79:561-567 

Baggish AL et al
Long-term anabolic-androgenic steroid use isassociated with left ventricular dysfunction
Circ Heart Fail. 2010 Jul;3(4):472-6

Basaria S et al
Adverse events associated with testosterone administration"
N Engl J Med. 2010 Jul 8;363(2):109-22

Bhasin, S et al
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
New England Journal of Medicine, 1996 335:1-7

Birgner, Carolina
Anabolic androgenic steroids and central monoaminergic systems: Supratherapeutic doses of nandrolone decanoate affect dopamine and serotonin
Uppsala Universitetet, 2008 

Bonetti, Antonio et al
Side Effects of Anabolic Androgenic Steroids Abuse
International Journal of Sports Medicin, 2008; 29: 679-687 (Läs artikel om studien här)

Brusca MI et al
Anabolic steroids affect human periodontal health and microbiota
Clin Oral Investig. 2013 Nov 13

Dickermann, R. D. et al
Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids
Cardiology, 1995 86:172-173

DiMeo AN, Wood RI
Self-administration of estrogen and dihydrotestosterone in male hamsters
Horm Behav. 2006, 49(4):519-26.

DiMeo AN, Wood RI
ICV testosterone induces Fos in male Syrian hamster brain
Psychoneuroendocrinology. 2006. 31(2):237-49.

Egner IM, Bruusgaard JC, Eftestøl E, Gundersen K
A cellular memory mechanism aids overload hypertrophy in muscle long after an episodic exposure to anabolic steroids
J Physiol. 2013 Dec 15;591(Pt 24):6221-30

Ehrnborg, C et al
Growth hormone abuse
Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Mar;14(1):71-7.

Elashoff, J. D  et al
Effects of anabolic-androgenic steroids on muscular strength
Annals of Internal Medicine, 1991 115:387-393

Fanton, L. et al
Heart lesions associated with anabolic steroid abuse: Comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits
Experimantal and Toxicologic Pathology: the official journal of Gesellschaft fur Toxikologische Pathologie, 2008 Nov 20

Far, HR et al
Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings
Cardiovasc Pathol. 2012 Jul-Aug;21(4):312-6

Fineschi V. et al
Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders
Int J Legal Med. 2007 Jan;121(1):48-53. Epub 2005 Nov 15.

Finkelstein, JS et al
Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men
N Engl J Med. 2013 Dec 19;369(25):2457

Giorgi A, Weatherby RP & Murphy PW
Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study
J Sci of Med Sport. 1999 Dec;2(4):341-55.

Golestani, R et al
Adverse cardiovascular effects of anabolic steroids: pathophysiology imaging
Eur J Clin Invest. 2012 Jul;42(7):795-803

Graham, MR et al
Short-term recombinant human growth hormone administration improves respiratory function in abstinent anabolic-androgenic steroid users
Growth Horm IGF Res. 2007 Aug;17(4):328-35.

Grönbladh, A et al
The impact of nandrolone decanoate and growthhormone on biosynthesis of steroids in rats
Steroids. 2013 Dec 11;78(12-13):1192-9

Forbes, G. B
The effect of anabolic steroids on lean body mass: the dose response curve
Metabolism: Clinical and Experimental, 1985 34:571-573  

Forbes G. B et al
Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped
JAMA: The Journal of the American Medical Association, 1992 267:397-399

Gerber, PA et al
The dire consequences of doping
Lancet. 2008 Aug 23;372(9639):656.

Hall, R. C
Abuse of supraphysiologic doses of anabolic steroids
Southern Medical Journal, 2005, 98(5), 550-555

Higgins, JP et al
Androgen abuse and increased cardiac risk
South Med J. 2012 Dec;105(12):670-4

Horns S et al
Self-reported anabolic-androgenic steroids use and musculoskeletal injuries: findings from the center for the study of retired athletes health survey of retired NFL players
Am J Phys Med Rehabil.2009 Mar;88(3):192-200

Isenberg J et al
Successive ruptures of patellar and Achilles tendons. Anabolic steroids in competitive sports
Unfallchirurg. 2008 Jan;111(1):46-9

Kasikcioglu E et al
Androgenic anabolic steroids also impair right ventricular function
Int J Cardiol. 2009 May 1;134(1):123-5

Kanayama, G. et al
Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study
Drug and Alcohol Dependence 2003 Jul 20;71(1):77-86.

Kicman, AT
Biochemical and physiological aspects of endogenous androgens
Handb Exp Pharmacol. 2010;(195):25-64

Kicman, AT
Pharmacology of anabolic steroids
Br J Pharmacol. 2008 Jun;154(3):502-21

Kraus, SL et al
The dark side of beauty: acne fulminans induced by anabolic steroids in a male bodybuilder
Arch Dermatol. 2012 Oct;148(10):1210-2

Malarkey WB et al
Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids
Am J Obstet Gynecol.1991 Nov;165(5 Pt 1):1385-90

Melnik, B et al
Abuse of anabolic-androgenic steroids and bodybuildingacne: an underestimated health problem
J Dtsch Dermatol Ges. 2007 Feb;5(2):110-7

Montisci M et al
Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases
Forensic Sci Int. 2012 Apr 10;217(1-3):e13-8

Nordström A. et al
Higher muscle mass but lower gynoid fat mass in athletes using anabolic androgenic steroids
Journal of Strength and Conditioning Research vol. 26:1, 2012, 246-250

Olivardia, Roberto, Ph.D. et al
Muscle Dysmorphia in Male Weightlifters: A Case-Control Study
The American Journal of Psychiatry, 157:1291-1296, August 2000

Petersson A et al
Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids
Drug Alcohol Depend. 2006 Feb 28;81(3):241-9. Epub 2005 Aug 30.

Petersson A et al
Morbidity and mortality in patients testing positively for the presence of anabolic androgenic steroids in connection with receiving medical care. A controlled retrospective cohort study
Drug Alcohol Depend. 2006 Feb 28;81(3):215-20.

Sánchez-Osorio M et al
Anabolic–androgenic steroids and liver injury
Liver Int. 2008 Feb;28(2):278-82

Skogastierna, C. et al
A supraphysiological dose of testosterone induces nitric oxide production and oxidative stress
Eur J Prev Cardiol.2013 Mar 7

Schwingel PA et al
Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease
Liver Int. 2011 Mar;31(3):348-53

Stimac D et al
Androgenic/Anabolic steroid-induced toxic hepatitis
J Clin Gastroenterol. 2002 Oct;35(4):350-2

Thiblin I et al
Sudden unexpected death in a female fitness athlete, with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine
Forensic Sci Int. 2009 Jan 30;184(1-3):e7-11

Thiblin I et al
Cause and manner of death among users of anabolic androgenic steroids
J Forensic Sci. 2000 Jan;45(1):16-23

Vargas RA et al
The prostate after administration of anabolicandrogenic steroids: a morphometrical study in rats
Int Braz J Urol.2013 Sep-Oct;39(5):675-82

Venâncio DP et al
Effects of anabolic androgenic steroids on sleeppatterns of individuals practicing resistance exercise
Eur J Appl Physiol.2008 Mar;102(5):555-60

 Wingert, N. et al
Acute hepatitis and personality change in a 31-year-old man taking prohormone supplement SUS500
Psychosomatics 2010 Jul;51(4):340-4

Woerdeman J, de Ronde W
Therapeutic effects of anabolic androgenicsteroids on chronic diseases associated with muscle wasting
Expert Opin Investig Drugs. 2011 Jan;20(1):87-97

Xu L et al
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomizedtrials
BMC Med. 2013 Apr 18;11:108

Ställ en fråga